Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves.
📌 BeiGene $ONC — Baker Bros. Advisors increased its 13D stake from 0.61% to 8.00%.
That’s a massive jump in ownership—and when the Baker Bros show up like this, it matters. Their track record in biotech speaks for itself.
With the stock nearing completion of a major base, this is one we’re watching closely.
📌 CytomX Therapeutics $CTMX — Point72 Asset Management increased its 13G stake from 3.06% to 5.00%.
The multi-strat fund nearly doubled its position, crossing the key 5% threshold in the beaten-down oncology name, signaling growing interest in the space.
Here’s The Hot Corner, with data from April 16, 2026:
📌 Rep. August Pfluger — Disclosed a broad basket of purchases, all ranging from $15,000 - $50,000 in U-Haul $UHAL, Berkshire Hathaway $BRK-B, Dorchester Minerals $DMLP, Enterprise Products Partners $EPD, and Viper Energy $VNOM.
